跳到正文
原文
Endpoints News 生物医药· Lei Lei Wu·· 2026-10-13精选AI 评分73

BioNTech 头颈癌 mRNA 疫苗未达两项主要终点之一

BioNTech’s head and neck cancer vaccine misses first of two goals

AI 导读

BioNTech 的头颈癌 mRNA 疫苗在关键试验中未达两项主要终点之一。

推荐理由

BioNTech 头颈癌 mRNA 疫苗在关键试验中未达两项主要终点之一,为 mRNA 肿瘤疫苗的临床路径提供了一处参考。

正文 · 原文

An ex­per­i­men­tal mR­NA can­cer vac­cine from BioN­Tech failed to meet one of two pri­ma­ry end­points in a piv­otal tri­al, adding to the ob­sta­cles faced by …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news